Showing 1 - 2 results of 2 for search 'Craig Underhill', query time: 0.01s Refine Results
  1. 1
    Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors

    Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors by Wenjing Wang, Yu Xia, Charlotte Lemech, Adnan Nagrial, Baiyong Li, Zhongmin Maxwell Wang, Sophia Frentzas, Anna Rachelle Austria Mislang, Craig Underhill, Jermaine I G Coward

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Pharmacogenetic‐guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC‐PGx): A multicenter clinical trial

    Pharmacogenetic‐guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC‐PGx): A multicenter clinical trial by Sarah Glewis, Senthil Lingaratnam, Benjamin Lee, Ian Campbell, Maarten IJzerman, Mussab Fagery, Sam Harris, Chloe Georgiou, Craig Underhill, Mark Warren, Robert Campbell, Madawa Jayawardana, S. Sandun M. Silva, Jennifer H. Martin, Jeanne Tie, Marliese Alexander, Michael Michael

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: